12
Participants
Start Date
April 30, 2014
Primary Completion Date
May 31, 2016
Study Completion Date
June 30, 2016
exendin 9-39
Exendin 9-39 is a specific GLP-1 receptor antagonist
sitagliptin
DPP-4 Inhibition
Placebo
Saline
Hvidovre University Hospital, Hvidovre
University of Copenhagen
OTHER
Hvidovre University Hospital
OTHER